Markets
Tech
Media
Success
Video
Markets
Premarkets
Dow
After-Hours
Market Movers
Fear & Greed
World Markets
Investing
Markets Now
Before the Bell
Leading Indicator
Global Energy Challenge
Economy
Tracking America's Recovery
Energy
Tech
Innovate
Gadget
Mission: Ahead
Upstarts
Business Evolved
Work Transformed
Innovative Cities
Unhackable
Media
Reliable Sources
Success
Boss Files
Fresh Money
Cars
Homes
Biz + Leisure
Center Piece
Perspectives
Video
International
Switzerland
India
Davos
Passion to Portfolio
On: Germany
More
Newsletters
About Us
Accessibility and CC
U.S.
World
Politics
Business
Opinion
Health
Entertainment
Tech
Style
Travel
Sports
Video
Shop
VR
More...
Follow CNN Business
Do Not Sell
Sesen Bio Inc
(NASDAQ:SESN)
Real-Time Quotes
0.8398
BATS BZX Real-Time Price
As of
3:18pm ET
-0.0002
/
-0.02%
Today’s Change
0.37
Today
|||
52-Week Range
6.04
+3.04%
Year-to-Date
Quote
Profile
News
Charts
Forecasts
Financials
Shareholders
Competitors
Latest SESN News
|
Press Releases
AstraZeneca (AZN) to Buy TeneoTwo, Boost Hematology Pipeline
Jul 05 / Zacks.com - Paid Partner Content
Kezar (KZR) Doubles on Promising Kidney Disorder Study Data
Jun 28 / Zacks.com - Paid Partner Content
Endo (ENDP) Phase II Study for Frozen Shoulder Disappoints
Jul 04 / Zacks.com - Paid Partner Content
Sanofi (SNY) Wins Nod for Nexviadyme & Xenpozyme in Europe
Jun 28 / Zacks.com - Paid Partner Content
Sanofi's (SNY) Studies on BTK Inhibitor Put on Hold by FDA
Jul 01 / Zacks.com - Paid Partner Content
Axsome (AXSM) Surges Following FDA Label Proposal for AXS-05
Jun 28 / Zacks.com - Paid Partner Content
Novartis (NVS) Announces Positive Data on Oncology Drug
Jul 01 / Zacks.com - Paid Partner Content
Gilead (GILD) Resubmits NDA for HIV Inhibitor to the FDA
Jun 28 / Zacks.com - Paid Partner Content
Axsome (AXSM) Hurt by Regulatory Setbacks: Will It Recover?
Jun 30 / Zacks.com - Paid Partner Content
Epizyme (EPZM) Stock Surges on Acquisition Offer From Ipsen
Jun 27 / Zacks.com - Paid Partner Content
Pfizer (PFE) Inks Deal With US Government for COVID Jab Supply
Jun 30 / Zacks.com - Paid Partner Content
Emergent's (EBS) Anthrax Vaccine BLA Gets FDA Acceptance
Jun 27 / Zacks.com - Paid Partner Content
Regeneron (REGN) Eylea sBLA for Extended Regimen Accepted
Jun 30 / Zacks.com - Paid Partner Content
Merck (MRK) Keytruda Gets Europe Nod for Expanded Melanoma Use
Jun 27 / Zacks.com - Paid Partner Content
Pfizer (PFE) Discloses Autoimmune Drug Deal With Priovant
Jun 29 / Zacks.com - Paid Partner Content
F-star (FSTX) Stock Rises on Buyout Offer From Sino Biopharm
Jun 24 / Zacks.com - Paid Partner Content
Gilead's (GILD) Yescarta Gets EC Nod for Follicular Lymphoma
Jun 29 / Zacks.com - Paid Partner Content
Sarepta (SRPT) Down on Clinical Hold on DMD Candidate SRP-5051
Jun 24 / Zacks.com - Paid Partner Content
4 Reasons Why Investors Should Buy Merck (MRK) Stock Now
Jun 29 / Zacks.com - Paid Partner Content
Merck's (MRK) Pneumococcal Vaccine Gets FDA Nod for Kids
Jun 23 / Zacks.com - Paid Partner Content
AstraZeneca (AZN) Drugs Get CHMP Recommendation for Breast Cancer
Jun 28 / Zacks.com - Paid Partner Content